SCIENTURE HOLDINGS, INC. Income (Loss) from Equity Method Investments
SCIENTURE HOLDINGS, INC. (SCNX) reported Income (Loss) from Equity Method Investments of -$250.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2020-03-30
- SCIENTURE HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2019-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2019-09-30 was -$162.18K.
- SCIENTURE HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2019-06-30 was -$58.85K.
- SCIENTURE HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2019-03-31 was -$28.97K.
- SCIENTURE HOLDINGS, INC. income (loss) from equity method investments for fiscal 2019 was -$250.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$162.18K derived: sum of 2 quarters · filed 2020-03-30 | -$221.03K derived: sum of 3 quarters · filed 2020-03-30 | -$250.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | -$162.18K 10-Q · filed 2019-10-28 | -$221.03K derived: sum of 2 quarters · filed 2019-10-28 | -$250.00K 10-Q · filed 2019-10-28 | |
| 2019-06-30 | -$58.85K 10-Q · filed 2019-07-26 | -$87.82K 10-Q · filed 2019-07-26 | ||
| 2019-03-31 | -$28.97K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |